PURPOSE 1) To describe the effectiveness and safety of thrombolytic therapy in patients
with acute atherothrombotic and embolic stroke and 2) to study the variables of the occlusion …

An open angiography‐based, dose rate escalation study on the effect of intravenous
infusion of recombinant tissue plasminogen activator (rt‐PA) on cerebral arterial …

Background and Purpose—Recanalization rates after the intravenous (IV) recombinant
tissue plasminogen activator (rt-PA) treatment have been poorly studied in acute stroke …

BACKGROUND AND PURPOSE: The effect of vessel patency, following recombinant tissue
plasminogen activator (rtPA) administration, on clinical outcome in acute ischemic stroke …

In a feasibility and safety study of thrombolytic therapy in acute ischemic stroke, we explored
the usefulness of measurements of regional cerebral blood flow. Twenty-three patients with …

BACKGROUND AND PURPOSE: Early reocclusion of recanalized arteries has been
observed after thrombolysis for acute coronary occlusion and has been attributed to platelet …

To determine the effect of intravenous recombinant tissue plasminogen activator (rt-PA) on
vascular and neurologic outcomes, we enrolled 31 patients with acute carotid artery-territory …

BACKGROUND AND PURPOSE: Since the approval of intravenous tissue plasminogen
activator for acute ischemic stroke, great interest has been generated in cerebral fibrinolysis …

Background and Purpose—We sought to evaluate predictors of clinical outcome,
angiographic success, and adverse effects after intra-arterial administration of urokinase for …

Abstract TO CLARIFY THE efficacy and limitations of the intra-arterial local infusion of a high-
dose fibrinolytic agent for acute embolic stroke, we analyzed the results of 44 patients and …